Inhibition of growth of a Philadelphia-chromosome positive acute lymphoblastic leukemia cell line by antisense oligonucleotides specific for the p190 bcr-abl oncogene

被引：0
|
作者：
Snyder, DS [1 ]
Wu, Y [1 ]
McMahon, R [1 ]
Forman, SJ [1 ]
机构：
[1] CITY HOPE NATL MED CTR,DUARTE,CA 91010
来源：
BLOOD | 1995年 / 86卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2956 / 2956
页数：1
相关论文
共 50 条
  • [21] A LATE-APPEARING PHILADELPHIA-CHROMOSOME IN ACUTE LYMPHOBLASTIC-LEUKEMIA CONFIRMED BY EXPRESSION OF BCR-ABL MESSENGER-RNA
    TSUCHIYA, H
    MIGITA, M
    YAMAMORI, S
    KANEKO, Y
    ADACHI, N
    NAKAMURA, T
    NOBUKUNI, Y
    ELSONBATY, SS
    MATSUDA, I
    LEUKEMIA, 1995, 9 (10) : 1689 - 1693
  • [22] Frequency of p190 and p210 BCR-ABL Fusions Genes in Acute Lymphoblastic Leukemia in a Long Group of Adults and Childhood
    Arana-Trejo, Rosa Maria
    Ignacio, Gregorio
    Amador-Sanchez, Raquel
    Cruz-Rico, Jorge
    Hernandez, Maria-Paula
    Saldivar, Israel
    Lugo, Yolanda
    Solis-Poblano, Juan-Carlos
    Perez, Oscar
    Tejeda, Monica
    Artristian, Alberto
    Solis-Anaya, Luis
    BLOOD, 2016, 128 (22)
  • [23] A novel maxizyme vector targeting a bcr-abl fusion gene induced specific cell death in Philadelphia chromosome-positive acute lymphoblastic leukemia
    Soda, Y
    Tani, K
    Bal, Y
    Saiki, M
    Chen, M
    Izawa, K
    Kobayashi, S
    Takahashi, S
    Uchimaru, K
    Kuwabara, T
    Warashina, M
    Tanabe, T
    Miyoshi, H
    Sugita, K
    Nakazawa, S
    Tojo, A
    Taira, K
    Asano, S
    BLOOD, 2004, 104 (02) : 356 - 363
  • [24] p190 BCR-ABL mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemias
    vanRhee, F
    Hochhaus, A
    Lin, F
    Melo, JV
    Goldman, JM
    Cross, NCP
    BLOOD, 1996, 87 (12) : 5213 - 5217
  • [25] PHILADELPHIA-CHROMOSOME POSITIVE B-CELL TYPE MALIGNANT-LYMPHOMA EXPRESSING AN ABERRANT 190 KDA BCR-ABL PROTEIN
    MITANI, K
    SATO, Y
    TOJO, A
    ISHIKAWA, F
    KOBAYASHI, Y
    MIURA, Y
    MIYAZONO, K
    URABE, A
    TAKAKU, F
    BRITISH JOURNAL OF HAEMATOLOGY, 1990, 76 (02) : 221 - 225
  • [26] The development of agents targeting the BCR-ABL tyrosine kinase as Philadelphia chromosome-positive acute lymphoblastic leukemia treatment
    Thomas, Xavier
    Heiblig, Mael
    EXPERT OPINION ON DRUG DISCOVERY, 2016, 11 (11) : 1061 - 1070
  • [27] EXPRESSION OF THE P190 BCR-ABL PROTEIN IN AN EBV IMMORTALIZED LYMPHOBLASTOID CELL-LINE
    YOUNG, BD
    GIBBONS, B
    CHAPLIN, T
    DHUT, S
    BRITISH JOURNAL OF CANCER, 1990, 61 (06) : 947 - 947
  • [28] The existence of lymphoid lineage restricted Philadelphia chromosome-positive acute lymphoblastic leukemia with heterogeneous bcr-abl rearrangement
    L Pajor
    JA Vass
    L Kereskai
    P Kajtár
    Á Szomor
    M Egyed
    J Iványi
    P Jáksó
    Leukemia, 2000, 14 : 1122 - 1126
  • [29] The existence of lymphoid lineage restricted Philadelphia chromosome-positive acute lymphoblastic leukemia with heterogeneous bcr-abl rearrangement
    Pajor, L
    Vass, JA
    Kereskai, L
    Kajtár, P
    Szomor, A
    Egyed, M
    Iványi, J
    Jáksó, P
    LEUKEMIA, 2000, 14 (06) : 1122 - 1126
  • [30] Drug resistance of secondary acute myeloid leukemia with megakaryoblastic features and p190 BCR-ABL rearrangement
    Veelken, H
    Licht, T
    Lais, A
    Köhler, G
    Mertelsmann, R
    Schaefer, HE
    Lübbert, M
    LEUKEMIA RESEARCH, 1998, 22 (11) : 1021 - 1027
12345